Decision to reject screening for familial hypercholesterolaemia is flawed

Arch Dis Child. 2021 Jun;106(6):525-526. doi: 10.1136/archdischild-2020-319168. Epub 2020 Jun 29.

Authors

David S Wald¹, Andrew C Martin²

Affiliations

¹ Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK d.s.wald@qmul.ac.uk.
² Dept of Paediatric and Adolescent Medicine, Princess Margaret Hospital for Children, Perth, Western Australia, Australia.

PMID: 32601084
DOI: 10.1136/archdischild-2020-319168

No abstract available

Keywords: cardiology; genetics.

MeSH terms

Cholesterol / blood
Decision Making, Organizational*
Genetic Testing / standards
Humans
Hyperlipoproteinemia Type II / blood
Hyperlipoproteinemia Type II / complications
Hyperlipoproteinemia Type II / diagnosis*
Hyperlipoproteinemia Type II / genetics
Mass Screening / organization & administration
Mass Screening / standards*
Mutation
Myocardial Infarction / genetics
Myocardial Infarction / prevention & control*
Practice Guidelines as Topic
State Medicine / standards*
Time Factors
United Kingdom

Substances

Cholesterol